首页|丁酸氯维地平注射用乳剂商业化生产工艺研究

丁酸氯维地平注射用乳剂商业化生产工艺研究

Study on commercial scale-up of the production process of clevidipine butyrate emulsion for injection

扫码查看
目的:通过优化丁酸氯维地平注射用乳剂制备工艺,确保能够在商业化生产线上制备出质量稳定的良好产品.方法:通过对蛋黄卵磷脂加入方式、制备初乳方式、均质参数和pH调节步骤的考察,筛选出符合商业化的丁酸氯维地平注射用乳剂的制备工艺.结果:采取蛋黄卵磷脂加入油相,油水两相按固定比例混合的方式制备初乳,均质压力采用 50~70 MPa,均质时药液温度控制在 40~60℃,均质次数为 5~12 次,均质后调节药液的pH调节至 7.0~8.0,可得到质量较好的丁酸氯维地平注射用乳剂.结论:采用优化后的工艺参数,能够在商业化生产线上制备出良好质量并稳定的丁酸氯维地平注射用乳剂.
Objective:To ensure that products with good quality and stability can be prepared on commercial production lines by optimizing the preparation process of clevidipine butyrate emulsion for injection.Methods:The preparation process of clevidipine butyrate emulsion for injection suitable for commercial production was screened out by the optimization of method for the addition of egg yolk lecithin,the investigation of the crude emulsion feeding sequence,homogenization parameters and pH adjustment steps.Results:A better quality clevidipine butyrate emulsion for injection could be obtained by adding egg yolk lecithin to the oil phase,mixing oil and water in a fixed proportion,setting the homogenization pressure at 50-70 MPa,maintaining the temperature of the liquid at 40-60℃,homogenizing the liquid for 5-12 times and adjusting the pH to 7.0-8.0.Conclusion:It is possible to prepare a good quality and stable clevidipine butyrate emulsion for injection using the optimized process parameters on a commercial production line.

clevidipine butyrate emulsion for injectionprocess optimizationcommercial production

崔智睿、陈辰

展开 >

上海上药第一生化药业有限公司 上海 200240

丁酸氯维地平注射用乳剂 工艺优化 商业化生产

2024

上海医药
上海医药行业协会

上海医药

影响因子:0.781
ISSN:1006-1533
年,卷(期):2024.45(15)